StockData
Passage BIO, Inc. logo

Passage BIO, Inc. (PASG) income statement

PASGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$3.92+0.31 (+8.59%)

Close on Nov 20, 2026Market cap $12.61MP/E –Yield –

See a number that looks wrong?